Efficacy of anti-amyloid-ß monoclonal antibody therapy in early Alzheimer’s disease: a systematic review and meta-analysis

被引：0
|
作者：
Julyana M. Dantas
Antonio Mutarelli
Denilsa D. P. Navalha
Caroline S. Dagostin
Pedro H. C. L. Romeiro
Nicole Felix
Alleh Nogueira
Sávio Batista
Larissa Teixeira
Paulo Caramelli
机构：
[1] Universidade Federal do Rio Grande do Norte,Behavioral and Cognitive Neurology Unit, Faculdade de Medicina
[2] Universidade Federal de Minas Gerais,undefined
[3] Universidade Eduardo Mondlane,undefined
[4] Universidade do Extremo Sul Catarinense,undefined
[5] Centro Universitário de Maceió,undefined
[6] Universidade Federal de Campina Grande,undefined
[7] Escola Bahiana de Medicina e Saúde Pública,undefined
[8] Universidade Federal do Rio de Janeiro,undefined
[9] Universidade Federal de Minas Gerais,undefined
来源：
Neurological Sciences | 2024年 / 45卷
关键词：
Alzheimer disease; Mild cognitive impairment; Monoclonal antibodies; Therapeutic; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2461 / 2469
页数：8
相关论文
共 50 条
  • [1] Efficacy of anti-amyloid-ß monoclonal antibody therapy in early Alzheimer's disease: a systematic review and meta-analysis
    Dantas, Julyana M.
    Mutarelli, Antonio
    Navalha, Denilsa D. P.
    Dagostin, Caroline S.
    Romeiro, Pedro H. C. L.
    Felix, Nicole
    Nogueira, Alleh
    Batista, Savio
    Teixeira, Larissa
    Caramelli, Paulo
    NEUROLOGICAL SCIENCES, 2024, 45 (06) : 2461 - 2469
  • [2] Safety and Efficacy of Anti-Amyloid-β Immunotherapy in Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Penninkilampi, Ross
    Brothers, Holly M.
    Eslick, Guy D.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2017, 12 (01) : 194 - 203
  • [3] Safety and Efficacy of Anti-Amyloid-β Immunotherapy in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
    Ross Penninkilampi
    Holly M. Brothers
    Guy D. Eslick
    Journal of Neuroimmune Pharmacology, 2017, 12 : 194 - 203
  • [4] Efficacy and safety of anti-amyloid-β immunotherapy for Alzheimer's disease: a systematic review and network meta-analysis
    Mo, Jia-Jie
    Li, Jin-yu
    Yang, Zheng
    Liu, Zhou
    Feng, Jin-Shan
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2017, 4 (12): : 931 - 942
  • [5] The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials
    Wenxue Wu
    Yi Ji
    Zilan Wang
    Xiaoxiao Wu
    Jiaxuan Li
    Feng Gu
    Zhouqing Chen
    Zhong Wang
    European Journal of Medical Research, 28
  • [6] The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials
    Wu, Wenxue
    Ji, Yi
    Wang, Zilan
    Wu, Xiaoxiao
    Li, Jiaxuan
    Gu, Feng
    Chen, Zhouqing
    Wang, Zhong
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [7] Critical assessment of anti-amyloid-β monoclonal antibodies effects in Alzheimer's disease: a systematic review and meta-analysis highlighting target engagement and clinical meaningfulness
    Avgerinos, Konstantinos I.
    Manolopoulos, Apostolos
    Ferrucci, Luigi
    Kapogiannis, Dimitrios
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [8] Efficacy and safety of anti-amyloid-β monoclonal antibodies in current Alzheimer's disease phase III clinical trials: A systematic review and interactive web app-based meta-analysis
    Jeremic, Danko
    Navarro-Lopez, Juan D.
    Jimenez-Diaz, Lydia
    AGEING RESEARCH REVIEWS, 2023, 90
  • [9] Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise
    van Dyck, Christopher H.
    BIOLOGICAL PSYCHIATRY, 2018, 83 (04) : 311 - 319
  • [10] Monoclonal therapy with lecanemab in the treatment of mild Alzheimer's disease: A systematic review and meta-analysis
    Arroyo-Pacheco, Nelson
    Sarmiento-Blanco, Shayury
    Vergara-Cadavid, Guillermo
    Castro-Leones, Maryarena
    Contreras-Puentes, Neyder
    AGEING RESEARCH REVIEWS, 2025, 104
12345